Loading…
Loading…
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026 at 07:45 a.m. Eastern Time.
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, September 19, 2026, in support of Prostate Cancer Awareness Month.
LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Greg Sorensen, Executive Vice President and Chief Strategy Officer, will be presenting at the Jefferies Healthcare Services Conference on Tuesday, September 15, 2026 at 9:10 a.m.
Bamco Inc. NY acquired a new stake in RadNet, Inc. (NASDAQ: RDNT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,260,992 shares of the medical research company's stock, valued at approximately $77,765,000. Bamco Inc. NY owned about 1.60% of
Oncology Institute (NASDAQ: TOI - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Analyst Ratings This is a summary of current ratings
RDNT's advanced imaging mix is expanding. I think this will continue to support its improving revenue quality and margins. RDNT's joint ventures across healthcare systems also help it deepen its integration across customers' workflows. DeepHealth is RDNT's second growth leg, as it pairs external software sales with internal workflow efficiencies.
RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
RadNet, Inc. (NASDAQ: RDNT - Get Free Report)'s stock price rose 6.9% during trading on Monday following a stronger than expected earnings report. The stock traded as high as $74.41 and last traded at $77.4050. Approximately 156,969 shares traded hands during trading, a decline of 81% from the average session volume of 830,771 shares. The stock